300583 赛托生物
已收盘 08-30 15:00:00
资讯
新帖
简况
赛托生物（300583）2024年中报简析：净利润减77.97%
证券之星 · 08-28
赛托生物（300583）2024年中报简析：净利润减77.97%
图解赛托生物中报：第二季度单季净利润同比减77.27%
证券之星 · 08-27
图解赛托生物中报：第二季度单季净利润同比减77.27%
赛托生物最新公告：2024年上半年净利润同比下降77.97%
证券之星 · 08-26
赛托生物最新公告：2024年上半年净利润同比下降77.97%
赛托生物(300583.SZ)发布上半年业绩，净利润1321.14万元，下降77.97%
智通财经 · 08-26
赛托生物(300583.SZ)发布上半年业绩，净利润1321.14万元，下降77.97%
赛托生物（300583）8月20日主力资金净卖出1644.37万元
证券之星 · 08-20
赛托生物（300583）8月20日主力资金净卖出1644.37万元
赛托生物最新公告：布地奈德获得化学原料药上市申请批准通知书
证券之星 · 08-19
赛托生物最新公告：布地奈德获得化学原料药上市申请批准通知书
8月16日赛托生物涨8.88%，华安创业板两年定开混合基金重仓该股
证券之星 · 08-16
8月16日赛托生物涨8.88%，华安创业板两年定开混合基金重仓该股
赛托生物（300583）8月13日主力资金净卖出415.78万元
证券之星 · 08-13
赛托生物（300583）8月13日主力资金净卖出415.78万元
赛托生物（300583）8月12日主力资金净买入315.74万元
证券之星 · 08-12
赛托生物（300583）8月12日主力资金净买入315.74万元
赛托生物（300583）8月9日主力资金净卖出255.43万元
证券之星 · 08-09
赛托生物（300583）8月9日主力资金净卖出255.43万元
赛托生物（300583）8月7日主力资金净买入17.57万元
证券之星 · 08-07
赛托生物（300583）8月7日主力资金净买入17.57万元
赛托生物涨5.44%，中邮证券二个月前给出“买入”评级
证券之星 · 08-06
赛托生物涨5.44%，中邮证券二个月前给出“买入”评级
8月5日赛托生物跌6.02%，华安创业板两年定开混合基金重仓该股
证券之星 · 08-05
8月5日赛托生物跌6.02%，华安创业板两年定开混合基金重仓该股
赛托生物（300583）8月5日主力资金净卖出2481.16万元
证券之星 · 08-05
赛托生物（300583）8月5日主力资金净卖出2481.16万元
7月31日赛托生物跌6.85%，华安创业板两年定开混合基金重仓该股
证券之星 · 07-31
7月31日赛托生物跌6.85%，华安创业板两年定开混合基金重仓该股
赛托生物（300583）7月31日主力资金净卖出2996.60万元
证券之星 · 07-31
赛托生物（300583）7月31日主力资金净卖出2996.60万元
2连板赛托生物：公司、控股股东及实控人不存在关于公司应披露而未披露的重大事项
证券之星 · 07-30
2连板赛托生物：公司、控股股东及实控人不存在关于公司应披露而未披露的重大事项
7月30日赛托生物（300583）龙虎榜数据：游资宁波桑田路、量化打板上榜
证券之星 · 07-30
7月30日赛托生物（300583）龙虎榜数据：游资宁波桑田路、量化打板上榜
赛托生物涨19.97%，中邮证券二个月前给出“买入”评级
证券之星 · 07-30
赛托生物涨19.97%，中邮证券二个月前给出“买入”评级
异动快报：赛托生物（300583）7月30日9点39分触及涨停板
证券之星 · 07-30
异动快报：赛托生物（300583）7月30日9点39分触及涨停板
公司概况
公司名称：
山东赛托生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2017-01-06
主营业务：
山东赛托生物科技股份有限公司是一家应用基因工程技术和微生物转化技术制造甾体药物原料的企业。公司产品有雄烯二酮（4-AD）、雄二烯二酮（ADD）、9-羟基雄烯二酮（9OH-AD）、四烯物（3TR）、甲羟环氧孕酮（8DM）等甾体药物原料及中间体。公司入围工业和信息化部办公厅第五批绿色制造名单，获评山东省十强产业集群领军企业，山东省“专精特新”中小企业荣誉称号。
发行价格：
40.29
{"stockData":{"symbol":"300583","market":"SZ","secType":"STK","nameCN":"赛托生物","latestPrice":12.7,"timestamp":1725001380000,"preClose":12.53,"halted":0,"volume":3109660,"delay":0,"floatShares":186000000,"shares":190000000,"eps":-0.0061,"marketStatus":"已收盘","marketStatusCode":5,"change":0.17,"latestTime":"08-30 15:00:00","open":12.58,"high":12.93,"low":12.43,"amount":39737000,"amplitude":0.0399,"askPrice":12.71,"askSize":969,"bidPrice":12.7,"bidSize":18,"shortable":0,"etf":0,"ttmEps":-0.0061,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1725240600000},"adr":0,"adjPreClose":12.53,"symbolType":"stock","openAndCloseTimeList":[[1724981400000,1724988600000],[1724994000000,1725001200000]],"highLimit":13.78,"lowLimit":11.28,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":189702126,"pbRate":1.22,"roa":"--","roe":"0.65%","epsLYR":0.25,"committee":-0.831672,"marketValue":2409000000,"floatMarketCap":2364000000,"peRate":-2081.967253,"changeRate":0.0136,"turnoverRate":0.0167,"status":0},"requestUrl":"/m/hq/s/300583/wiki","defaultTab":"wiki","newsList":[{"id":"2462238261","title":"赛托生物（300583）2024年中报简析：净利润减77.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462238261","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462238261?lang=zh_cn&edition=full","pubTime":"2024-08-28 06:23","pubTimestamp":1724797410,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期赛托生物发布2024年中报。根据财报显示，赛托生物净利润减77.97%。截至本报告期末，公司营业总收入5.67亿元，同比下降14.62%，归母净利润1321.14万元，同比下降77.97%。按单季度数据看，第二季度营业总收入3.22亿元，同比下降2.01%，第二季度归母净利润1014.06万元，同比下降77.27%。经营活动产生的现金流量净额变动幅度为173.98%,原因:报告期内以现金方式支付的原材料款减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800007684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583"],"gpt_icon":0},{"id":"2462494944","title":"图解赛托生物中报：第二季度单季净利润同比减77.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462494944","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462494944?lang=zh_cn&edition=full","pubTime":"2024-08-27 01:29","pubTimestamp":1724693389,"startTime":"0","endTime":"0","summary":"证券之星消息，赛托生物2024年中报显示，公司主营收入5.67亿元，同比下降14.62%；归母净利润1321.14万元，同比下降77.97%；扣非净利润505.0万元，同比下降86.4%；其中2024年第二季度，公司单季度主营收入3.22亿元，同比下降2.01%；单季度归母净利润1014.06万元，同比下降77.27%；单季度扣非净利润354.86万元，同比下降84.16%；负债率38.23%，投资收益967.12万元，财务费用1763.13万元，毛利率25.81%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700001935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583"],"gpt_icon":0},{"id":"2462994384","title":"赛托生物最新公告：2024年上半年净利润同比下降77.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462994384","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462994384?lang=zh_cn&edition=full","pubTime":"2024-08-26 20:20","pubTimestamp":1724674853,"startTime":"0","endTime":"0","summary":"赛托生物发布2024年半年度报告，报告期内，公司实现营业收入5.67亿元，同比下降14.62%；归属于上市公司股东的净利润为1321.14万元，同比下降77.97%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082600031005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583"],"gpt_icon":0},{"id":"2462967231","title":"赛托生物(300583.SZ)发布上半年业绩，净利润1321.14万元，下降77.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462967231","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462967231?lang=zh_cn&edition=full","pubTime":"2024-08-26 18:31","pubTimestamp":1724668317,"startTime":"0","endTime":"0","summary":"智通财经APP讯，赛托生物(300583.SZ)发布2024年半年度报告，该公司营业收入为5.67亿元，同比减少14.62%。归属于上市公司股东的净利润为1321.14万元，同比减少77.97%。归属于上市公司股东的扣除非经常性损益的净利润为505万元，同比减少86.40%。基本每股收益为0.07元。报告期内，公司继续践行研发先行的方针，加大新产品开发力度，丰富产品线，加快原料药、制剂的产品储备。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1170750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300583"],"gpt_icon":0},{"id":"2460238000","title":"赛托生物（300583）8月20日主力资金净卖出1644.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460238000","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460238000?lang=zh_cn&edition=full","pubTime":"2024-08-20 15:26","pubTimestamp":1724138769,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月20日收盘，赛托生物报收于12.99元，下跌4.2%，换手率3.91%，成交量7.26万手，成交额9564.01万元。赛托生物主营业务：致力于应用基因工程技术和微生物转化技术研发与生产甾体药物原料,是国内首家规模化采用合成生物法制取甾体药物原料的生产商,并逐步发展为甾体药物原料龙头供应商。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082000019081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300583"],"gpt_icon":0},{"id":"2460877360","title":"赛托生物最新公告：布地奈德获得化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2460877360","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460877360?lang=zh_cn&edition=full","pubTime":"2024-08-19 19:30","pubTimestamp":1724067004,"startTime":"0","endTime":"0","summary":"赛托生物公告，公司控股子公司山东斯瑞药业有限公司近日收到国家药品监督管理局签发的布地奈德《化学原料药上市申请批准通知书》。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081900027226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"gpt_icon":0},{"id":"2459262938","title":"8月16日赛托生物涨8.88%，华安创业板两年定开混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459262938","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459262938?lang=zh_cn&edition=full","pubTime":"2024-08-16 16:14","pubTimestamp":1723796065,"startTime":"0","endTime":"0","summary":"证券之星消息，8月16日赛托生物涨8.88%，收盘报13.73元，换手率6.82%，成交量12.66万手，成交额1.7亿元。重仓赛托生物的公募基金请见下表：根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华安创业板两年定开混合。华安创业板两年定开混合目前规模为1.32亿元，最新净值0.9633，较上一交易日下跌2.61%，近一年下跌23.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081600031875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000001.SH","159915","BK0239","159982","399300","399006","300583"],"gpt_icon":0},{"id":"2459942928","title":"赛托生物（300583）8月13日主力资金净卖出415.78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459942928","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459942928?lang=zh_cn&edition=full","pubTime":"2024-08-13 15:24","pubTimestamp":1723533856,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月13日收盘，赛托生物报收于12.71元，下跌1.85%，换手率2.66%，成交量4.94万手，成交额6287.74万元。赛托生物主营业务：致力于应用基因工程技术和微生物转化技术研发与生产甾体药物原料,是国内首家规模化采用合成生物法制取甾体药物原料的生产商,并逐步发展为甾体药物原料龙头供应商。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300025210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"gpt_icon":0},{"id":"2458077627","title":"赛托生物（300583）8月12日主力资金净买入315.74万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458077627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458077627?lang=zh_cn&edition=full","pubTime":"2024-08-12 15:19","pubTimestamp":1723447181,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月12日收盘，赛托生物报收于12.95元，上涨2.86%，换手率3.77%，成交量6.99万手，成交额9002.5万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：赛托生物2024年一季报显示，公司主营收入2.44亿元，同比下降27.0%；归母净利润307.07万元，同比下降80.0%；扣非净利润150.14万元，同比下降89.8%；负债率38.57%，投资收益178.79万元，财务费用1034.95万元，毛利率28.47%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200013195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"gpt_icon":0},{"id":"2458981532","title":"赛托生物（300583）8月9日主力资金净卖出255.43万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458981532","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458981532?lang=zh_cn&edition=full","pubTime":"2024-08-09 15:23","pubTimestamp":1723188205,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月9日收盘，赛托生物报收于12.59元，下跌4.98%，换手率5.34%，成交量9.9万手，成交额1.26亿元。赛托生物主营业务：致力于应用基因工程技术和微生物转化技术研发与生产甾体药物原料,是国内首家规模化采用合成生物法制取甾体药物原料的生产商,并逐步发展为甾体药物原料龙头供应商。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080900025789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"gpt_icon":0},{"id":"2457860346","title":"赛托生物（300583）8月7日主力资金净买入17.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457860346","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457860346?lang=zh_cn&edition=full","pubTime":"2024-08-07 15:23","pubTimestamp":1723015427,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月7日收盘，赛托生物报收于12.81元，下跌2.81%，换手率3.45%，成交量6.4万手，成交额8269.41万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：赛托生物2024年一季报显示，公司主营收入2.44亿元，同比下降27.0%；归母净利润307.07万元，同比下降80.0%；扣非净利润150.14万元，同比下降89.8%；负债率38.57%，投资收益178.79万元，财务费用1034.95万元，毛利率28.47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080700026978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300583"],"gpt_icon":0},{"id":"2457091583","title":"赛托生物涨5.44%，中邮证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2457091583","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457091583?lang=zh_cn&edition=full","pubTime":"2024-08-06 16:14","pubTimestamp":1722932087,"startTime":"0","endTime":"0","summary":"今日赛托生物涨5.44%，收盘报13.18元。2024年5月7日，中邮证券研究员蔡明子,陈成发布了对赛托生物的研报《中间体有望企稳回升，产业链延伸稳步推进》，该研报对赛托生物给出“买入”评级。研报中预计公司2024-2026年归母净利润分别为0.59/0.76/0.90亿元，对应EPS分别为0.31/0.40/0.47元，当前股价对应PE分别为47.20/36.55/31.06倍，持续推荐，给予“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为民生证券的王班。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080600030826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300583"],"gpt_icon":0},{"id":"2457743511","title":"8月5日赛托生物跌6.02%，华安创业板两年定开混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2457743511","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457743511?lang=zh_cn&edition=full","pubTime":"2024-08-05 16:29","pubTimestamp":1722846543,"startTime":"0","endTime":"0","summary":"证券之星消息，8月5日赛托生物跌6.02%，收盘报12.5元，换手率6.22%，成交量11.53万手，成交额1.47亿元。重仓赛托生物的公募基金请见下表：根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华安创业板两年定开混合。华安创业板两年定开混合目前规模为1.32亿元，最新净值0.9891，较上一交易日上涨1.13%，近一年下跌20.69%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080500020590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000001.SH","159982","399006","399300","159915","BK0239","300583"],"gpt_icon":0},{"id":"2457140697","title":"赛托生物（300583）8月5日主力资金净卖出2481.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457140697","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457140697?lang=zh_cn&edition=full","pubTime":"2024-08-05 15:29","pubTimestamp":1722842960,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月5日收盘，赛托生物报收于12.5元，下跌6.02%，换手率6.22%，成交量11.53万手，成交额1.47亿元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：赛托生物2024年一季报显示，公司主营收入2.44亿元，同比下降27.0%；归母净利润307.07万元，同比下降80.0%；扣非净利润150.14万元，同比下降89.8%；负债率38.57%，投资收益178.79万元，财务费用1034.95万元，毛利率28.47%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080500014393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"gpt_icon":0},{"id":"2455906445","title":"7月31日赛托生物跌6.85%，华安创业板两年定开混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455906445","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455906445?lang=zh_cn&edition=full","pubTime":"2024-07-31 16:48","pubTimestamp":1722415708,"startTime":"0","endTime":"0","summary":"证券之星消息，7月31日赛托生物跌6.85%，收盘报14.27元，换手率15.16%，成交量28.11万手，成交额4.17亿元。重仓赛托生物的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华安创业板两年定开混合。华安创业板两年定开混合目前规模为1.32亿元，最新净值0.978，较上一交易日上涨0.0%，近一年下跌21.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100034277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","159915","BK0239","159982","399006","399300","000001.SH"],"gpt_icon":0},{"id":"2455974198","title":"赛托生物（300583）7月31日主力资金净卖出2996.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455974198","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455974198?lang=zh_cn&edition=full","pubTime":"2024-07-31 15:24","pubTimestamp":1722410696,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月31日收盘，赛托生物报收于14.27元，下跌6.85%，换手率15.16%，成交量28.11万手，成交额4.17亿元。赛托生物主营业务：致力于应用基因工程技术和微生物转化技术研发与生产甾体药物原料,是国内首家规模化采用合成生物法制取甾体药物原料的生产商,并逐步发展为甾体药物原料龙头供应商。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100027192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"gpt_icon":0},{"id":"2455986971","title":"2连板赛托生物：公司、控股股东及实控人不存在关于公司应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2455986971","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455986971?lang=zh_cn&edition=full","pubTime":"2024-07-30 18:09","pubTimestamp":1722334196,"startTime":"0","endTime":"0","summary":"赛托生物发布股票交易异常波动公告，经核查，公司、控股股东及实际控制人不存在关于公司应披露而未披露的重大事项，或处于筹划阶段的重大事项。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073000036313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"gpt_icon":0},{"id":"2455600077","title":"7月30日赛托生物（300583）龙虎榜数据：游资宁波桑田路、量化打板上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2455600077","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455600077?lang=zh_cn&edition=full","pubTime":"2024-07-30 17:14","pubTimestamp":1722330891,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2024年7月30日公布的交易公开信息显示，赛托生物因日涨幅达到15%的前5只证券，连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2024年7月30日收盘，赛托生物报收于15.32元，上涨19.97%，已连续涨停2天，换手率10.69%，成交量19.82万手，成交额2.91亿元。宁波桑田路、量化打板等知名游资榜上有名。 从龙虎榜公布的三日买卖数据来看，机构合计净买入2164.68万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073000034701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300583"],"gpt_icon":0},{"id":"2455360122","title":"赛托生物涨19.97%，中邮证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2455360122","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455360122?lang=zh_cn&edition=full","pubTime":"2024-07-30 16:15","pubTimestamp":1722327335,"startTime":"0","endTime":"0","summary":"今日赛托生物涨19.97%，收盘报15.32元。2024年5月7日，中邮证券研究员蔡明子,陈成发布了对赛托生物的研报《中间体有望企稳回升，产业链延伸稳步推进》，该研报对赛托生物给出“买入”评级。研报中预计公司2024-2026年归母净利润分别为0.59/0.76/0.90亿元，对应EPS分别为0.31/0.40/0.47元，当前股价对应PE分别为47.20/36.55/31.06倍，持续推荐，给予“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为民生证券的王班。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073000030893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","161027"],"gpt_icon":0},{"id":"2455283216","title":"异动快报：赛托生物（300583）7月30日9点39分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2455283216","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455283216?lang=zh_cn&edition=full","pubTime":"2024-07-30 09:40","pubTimestamp":1722303646,"startTime":"0","endTime":"0","summary":"证券之星7月30日盘中消息，9点39分赛托生物触及涨停板。目前价格15.32，上涨19.97%。其所属行业化学制药目前上涨。领涨股为溢多利。该股为化学原料药，医药，辅助生殖概念热股，当日化学原料药概念上涨0.7%，医药概念上涨0.58%。7月29日的资金流向数据方面，主力资金净流入5229.06万元，占总成交额26.25%，游资资金净流出2008.78万元，占总成交额10.08%，散户资金净流出3220.28万元，占总成交额16.17%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073000014803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-01-06","address":"山东省菏泽市定陶区东外环路南段","stockEarnings":[{"period":"1week","weight":0.0418},{"period":"1month","weight":-0.11},{"period":"3month","weight":-0.007},{"period":"6month","weight":-0.2572},{"period":"1year","weight":-0.3102},{"period":"ytd","weight":-0.3353}],"companyName":"山东赛托生物科技股份有限公司","boardCode":"AI0027","perCapita":"12722股","boardName":"医药制造业","registeredCapital":"18970万元","compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.0329},{"period":"3month","weight":-0.0792},{"period":"6month","weight":-0.0611},{"period":"1year","weight":-0.089},{"period":"ytd","weight":-0.0446}],"survey":" 山东赛托生物科技股份有限公司是一家应用基因工程技术和微生物转化技术制造甾体药物原料的企业。公司产品有雄烯二酮（4-AD）、雄二烯二酮（ADD）、9-羟基雄烯二酮（9OH-AD）、四烯物（3TR）、甲羟环氧孕酮（8DM）等甾体药物原料及中间体。公司入围工业和信息化部办公厅第五批绿色制造名单，获评山东省十强产业集群领军企业，山东省“专精特新”中小企业荣誉称号。","serverTime":1725167320440,"listedPrice":40.29,"stockholders":"14631人(较上一季度增加16.85%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"赛托生物(300583)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供赛托生物(300583)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"赛托生物,300583,赛托生物股票,赛托生物股票老虎,赛托生物股票老虎国际,赛托生物行情,赛托生物股票行情,赛托生物股价,赛托生物股市,赛托生物股票价格,赛托生物股票交易,赛托生物股票购买,赛托生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"赛托生物(300583)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供赛托生物(300583)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}